SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-24-004110
Filing Date
2024-01-12
Accepted
2024-01-12 07:43:18
Documents
3
Period of Report
2024-01-11

Document Format Files

Seq Description Document Type Size
1 6-K 6-k_fy2024_q2_results.htm 6-K 26439
2 EX-99.1 vrax-ex99_1.htm EX-99.1 1049351
3 EX-99.2 vrax-ex99_2.htm EX-99.2 145810
  Complete submission text file 0000950170-24-004110.txt   1222739
Mailing Address 30 BROADWICK STREET LONDON X0 W1F 8LX
Business Address 30 BROADWICK STREET LONDON X0 W1F 8LX 44 020 7788 7414
Virax Biolabs Group Ltd (Filer) CIK: 0001885827 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41440 | Film No.: 24530592
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)